Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Coordination and Support Action · Running

hPSCreg human pluripotent stem cell registry - hPSCreg

Coordinator
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eV, Germany
Runs
1 May 2022 to 30 April 2027
Status
Running
EU funding
€1.5m
Total cost
€1.5m
Partners
1 organisations in 1 countries
Type
Coordination and Support Action
Grant agreement
101074135

What the project is doing

In the project's own words, from its summary on CORDIS.

The human pluripotent stem cell registry (hPSCreg) is providing validated information about human embryonic stem cells (ESC) and other human pluripotent stem cells (PSC) such as induced PSC. This information is linked through an unique persistent identifier and it includes data on ethical provenance and scientific quality, cell line application and clinical studies performed with hPSC. The open access Registry acts globally to provide a transparent resource and tool for PSC, to maximize cell utility, reproducibility and benefit and minimize research, ethical and regulatory risks.

It validates and certifies the registered cell lines based on the provided documents, data and information, assuring high quality of certified lines. hPSCreg is involved in multiple EU-Projects, international consortia and organizations to provide information, data standards and support dissemination. The main task of hPSCcreg within this project proposal are to maintain and improve its function as a centralized registry of hESC and hiPSC lines allowing for (i) transparent validation and monitoring of the ethical and scientific developments in the field; (ii) transparent data – based certification of PSC to assure and maintain highest quality; (iii) implementing FAIR data standards and a continuously improved data reliability in downstream stem cell research; (iv) supporting academic, industrial and clinical research on PSCs and maximizing their potential; and (v) inclusion of diverse stakeholders in the communication process on emerging PSC - based technologies, including research towards clinical applications.

Topics

Who is involved

OrganisationCityCountryRole
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eVMunchenGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI